All 3 Debates between Lord Kamall and Lord Lancaster of Kimbolton

Children: Cancer

Debate between Lord Kamall and Lord Lancaster of Kimbolton
Thursday 26th May 2022

(2 years, 6 months ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Lancaster of Kimbolton Portrait Lord Lancaster of Kimbolton
- Hansard - - - Excerpts

To ask Her Majesty’s Government what steps they are taking to improve cancer outcomes for children.

Lord Kamall Portrait The Parliamentary Under-Secretary of State, Department of Health and Social Care (Lord Kamall) (Con)
- Hansard - -

Cancer in children is thankfully rare, accounting for less than 1% of cancer cases each year. The Government are dedicated to improving cancer outcomes and our new 10-year cancer plan will further our efforts to improve childhood cancer diagnosis rates and outcomes. We continue to invest in research, including with the paediatric experimental cancer research centres network, which is dedicated to early-phase research on childhood cancers.

Lord Lancaster of Kimbolton Portrait Lord Lancaster of Kimbolton (Con)
- Hansard - - - Excerpts

My Lords, childhood cancer is not rare; it is the biggest killer by disease of children under 14 in the United Kingdom. Sadly, it is often diagnosed late and one in five children who get it will die. The issue was highlighted in the House of Commons last month in an excellent debate led by Caroline Dinenage. There, there was a cross-party consensus that, with just 3% of funding spent on children’s cancer, there needs to be greater emphasis on research, detection and treatment. Will childhood cancer be a priority for the Government’s 10-year cancer strategy and will the requested childhood cancer mission become a reality?

Lord Kamall Portrait Lord Kamall (Con)
- Hansard - -

I thank my noble friend for the question and for discussing the issue with me previously. As he rightly says, even though it is rare, cancer is the biggest killer of children aged up to about the age of 15. The Government’s new 10-year plan for cancer care is under development. It will address the cancer needs of the entire population, including those of children. We also recognise the severe impact that cancer has on not only the patient but their family and friends, and are focusing in particular on interventions that support patients through difficult journeys of diagnosis, treatment and aftercare.

New Hospitals

Debate between Lord Kamall and Lord Lancaster of Kimbolton
Thursday 18th November 2021

(3 years, 1 month ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Kamall Portrait Lord Kamall (Con)
- Hansard - -

One thing that is exciting about the new hospitals is that we are going to transform the way in which we deliver new healthcare infrastructure. First, it will be sustainable, with net-zero carbon across the NHS. Digital transformation is key, making use of the latest technology, so no longer will we have microscope slides couriered between sites, but we can instantly see a digital image and assess it using AI. There will be standardised design and modern methods of construction and new hospitals will be integrated with local health and care systems. This is a project for a health system that is fit for the future.

Lord Lancaster of Kimbolton Portrait Lord Lancaster of Kimbolton (Con)
- Hansard - - - Excerpts

Many of these new hospitals will be built in existing centres of population. My concern, though, is for areas of high projected population growth, such as the Oxford-Cambridge arc, where we always seem to be playing catch-up when it comes to medical facilities. Can my noble friend simply reassure me that the principles of “I before E”—infrastructure before expansion—will be applied when choosing where these hospitals will be?

Lord Kamall Portrait Lord Kamall (Con)
- Hansard - -

I assure my noble friend that, in deciding where to build a hospital, among the things that the NHS and others look at are the needs in the community, existing infrastructure and making sure that we can build hospitals that are fit for the future, that are digital, that are transformative, but are led by clinicians as opposed to construction experts.

Covid-19: Vaccinations Administered Abroad

Debate between Lord Kamall and Lord Lancaster of Kimbolton
Wednesday 27th October 2021

(3 years, 1 month ago)

Lords Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Lord Kamall Portrait Lord Kamall (Con)
- Hansard - -

The Covid pass can be accessed via the NHS app, but, where that is not possible, patients are able to go to the NHS website or to call 119 to get a letter version.

Lord Lancaster of Kimbolton Portrait Lord Lancaster of Kimbolton (Con)
- Hansard - - - Excerpts

I remind the House of my interest as a member of the Army Reserve. Many serving personnel and their families have been vaccinated overseas, either by defence medical services or local practitioners, and they too have had a challenge getting their vaccines on to the NHS app. Equally, in reverse, many serving reservists here in the United Kingdom have been unable to get their vaccinations on to JPA—the MoD administration system —meaning that there is a potential delay in their deployment. Since this is not an international problem but a national one between two government departments, can my noble friend simply use his good influences to sort it out?

Lord Kamall Portrait Lord Kamall (Con)
- Hansard - -

I thank my noble friend for making me aware of that issue; I was not aware of it. On the availability of the Covid pass, I repeat that the NHS Covid pass is available online and via NHS.UK, provided that individuals already have an NHS login. Users can then access it from anywhere in the world and download a Covid pass PDF. Individuals need to be in the UK to download the NHS app, but, once it is downloaded, it can be accessed worldwide. In terms of the conversations between the Department of Health and Social Care and the Ministry of Defence, I will make sure that I do that, and I will write to my noble friend.